NCT07365995 2026-01-26A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerBioNTech SEPhase 3 Not yet recruiting736 enrolled
NCT05401214 2025-06-13Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)Janssen Research & Development, LLCApproved for marketing